Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LPMX-2 by LipoMedix Pharmaceutical for Bladder Cancer: Likelihood of Approval
LPMX-2 is under clinical development by LipoMedix Pharmaceutical and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...